14 February 2018 - Deborah Wilkes
Archived
Worldwide sales at GlaxoSmithKline Consumer Healthcare increased by 2% at constant exchange rates to GBP7.75 billion (USD10.8 billion) in 2017. The company said its performance had been “impacted by slower global growth in key categories”.
New to OTCToolbox?
This is available as part of an Annual Subscription to the OTCToolbox website.